A risk score for the prognosis prediction of the muscle-invasive bladder cancer patients who received gemcitabine plus cisplatin chemotherapy

To develop an individualized gene-based risk score to predict the prognosis of muscle-invasive bladder cancer (MIBC) patients who received GC regimens. We downloaded transcriptome profiling data and clinical information from the Cancer Genome Atlas (TCGA) database. We identified 1854 survival-associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yupeng, Dong, Jing, Ji, Tao, Li, Xiaoxia, Rong, Shengzhong, Guan, Hongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792215/
https://www.ncbi.nlm.nih.gov/pubmed/36470668
http://dx.doi.org/10.18632/aging.204424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792215/
https://www.ncbi.nlm.nih.gov/pubmed/36470668
http://dx.doi.org/10.18632/aging.204424

Ejemplares similares